C4 Therapeutics Inc (CCCC) stock news · rev $35.9M
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
This CCCC news page leads with what C4 Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for CCCC yet. We will not pad this page with generic market recap.
Latest reported CCCC revenue for 2025-12-31 was $35.9M. Net income was -$105.0M. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. CCCC currently screens at market cap $425.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CCCC stock page; for the tape open the quote page.
CCCC stock news FAQ
What are CCCC's latest revenue and net income?
Latest cached C4 Therapeutics Inc (CCCC) revenue for Dec 31, 2025 was $35.9M. Net income was -$105.0M. Statements: https://lician.com/financials/cccc
How did CCCC revenue change from the prior cached period?
Cached C4 Therapeutics Inc (CCCC) revenue was up 1.0% from $35.6M (Dec 31, 2024) to $35.9M (Dec 31, 2025). Statements: https://lician.com/financials/cccc
What is CCCC's market cap?
C4 Therapeutics Inc (CCCC) market cap is $425.7M on the latest cached fundamentals snapshot.
What kind of company is CCCC?
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Where is CCCC stock news listed?
Cached stock news for C4 Therapeutics Inc (CCCC) is listed at https://lician.com/news/cccc. Filings: https://lician.com/sec/cccc
Not investment advice.